[Treatment of severe refractory psoriasis with infliximab. Clinical outcomes after one year of therapy].
Laura
L
Mahiques Santos
Teresa
T
Martínez Menchón
José Luis
JL
Sánchez Carazo
José Miguel
JM
Fortea Baixauli
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004351:Drug Resistance; D006801:Humans; D000069285:Infliximab; D011565:Psoriasis / Q000188:drug therapy* / Q000503:physiopathology; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab